- Home
- REXR vs TECH Comparison
REXR vs TECH Comparison
Compare REXR & TECH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- REXR
- TECH
- Stock Information
- Founded
- REXR 2013
- TECH 1976
- Country
- REXR United States
- TECH United States
- Employees
- REXR N/A
- TECH N/A
- Industry
- REXR Real Estate Investment Trusts
- TECH Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- REXR Real Estate
- TECH Health Care
- Exchange
- REXR Nasdaq
- TECH Nasdaq
- Market Cap
- REXR 7.7B
- TECH 7.8B
- IPO Year
- REXR 2013
- TECH 1989
- Fundamental
- Price
- REXR $35.71
- TECH $49.15
- Analyst Decision
- REXR Hold
- TECH Buy
- Analyst Count
- REXR 9
- TECH 10
- Target Price
- REXR $42.11
- TECH $73.44
- AVG Volume (30 Days)
- REXR 2.3M
- TECH 2.3M
- Earning Date
- REXR 04-16-2025
- TECH 05-07-2025
- Dividend Yield
- REXR 4.81%
- TECH 0.65%
- EPS Growth
- REXR 12.67
- TECH N/A
- EPS
- REXR 1.23
- TECH 0.83
- Revenue
- REXR $974,598,000.00
- TECH $1,208,770,000.00
- Revenue This Year
- REXR $9.99
- TECH $8.19
- Revenue Next Year
- REXR $8.93
- TECH $8.61
- P/E Ratio
- REXR $29.07
- TECH $59.07
- Revenue Growth
- REXR 18.04
- TECH 4.72
- 52 Week Low
- REXR $29.68
- TECH $46.44
- 52 Week High
- REXR $52.61
- TECH $85.57
- Technical
- Relative Strength Index (RSI)
- REXR 57.07
- TECH 44.74
- Support Level
- REXR $34.78
- TECH $46.35
- Resistance Level
- REXR $36.55
- TECH $54.40
- Average True Range (ATR)
- REXR 0.74
- TECH 2.17
- MACD
- REXR 0.42
- TECH 0.27
- Stochastic Oscillator
- REXR 80.33
- TECH 34.78
About REXR Rexford Industrial Realty Inc.
Rexford Industrial Realty Inc is a real estate investment trust engaged in owning, operating, and acquiring industrial properties in Southern California infill markets. The goal is to generate attractive risk-adjusted returns for stockholders by providing superior access to industrial property investments in Southern California infill markets. It has one operating segment business of investing in, operating, and repositioning/redeveloping industrial real estate properties located in Southern California infill markets.
About TECH Bio-Techne Corp
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.